Table 1.
Disease-Free Survival (DFS) | Variable | HR | 95% CI for HR | p-Value |
---|---|---|---|---|
PSA levels | <10 ng/mL | 1 (referent) | 0.086 | |
≥10 ng/mL | 2.607 | 1.116–6.089 | 0.027 | |
Pathological stage (pT) | pT2 | 1 (referent) | 0.028 | |
pT3a | 2.774 | 0.983–7.827 | 0.052 | |
pT3b | 3.902 | 1.264–12.045 | 0.018 | |
VIRMA/CCAT1/CCAT2 expression | VIRMAlow/lncRNAlow | 1 (referent) | 0.033 | |
VIRMAlow/lncRNAhigh | 2.475 | 0.978–6.259 | 0.041 | |
VIRMAhigh/lncRNAhigh | 9.083 | 1.911–43.183 | 0.006 |
HR – Hazard ratio; CI – Confidence interval; Statistically significant p-values (<0.05) are highlighted in bold.